MBX
#1752
MBX Biosciences, Inc. - Common Stock
60.0 4 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.65%
Variación mensual
+67.71%
Variación en los últimos 6 meses
+39.82%
Cambio anual
+327.03%
Cierres anteriores
61.0 5
Open
59.9 8
Mínimo
59.9 8
High
60.0 4
Volumen
85
Financials
- Market Capitalization 2.86 B
- Employee 63
- Founded 2018
- CEO N/A
- Website www.mbxbio.com
- Headquarter Delaware, United States
- FIGI BBG00W7W53M5
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1392 |  MANE Veradermics, Incorporated Common Stock | 110.00 USD | -7.99% | -12.07% | +13.50% | +233.33% | 4.60 B USD | ||
| 1581 |  OGN Organon & Co. Common Stock | 13.51 USD | -0.15% | -0.37% | +0.52% | +86.09% | 3.55 B USD | ||
| 1954 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 146.03 USD | +0.88% | +3.30% | +30.28% | +97.74% | 2.09 B USD | ||
| 2009 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 40.59 USD | -2.78% | +3.65% | +4.37% | +54.98% | 1.94 B USD |